Results 121 to 130 of about 11,407 (210)

Effectiveness of Ceftazidime/Avibactam treatment for infections caused by Klebsiella pneumoniae Carbapenemase (KPC), a 30-day mortality perspective. Comparison of results with control groups treated with other antibiotics

Journal of Education, Health and Sport
Introduction: Infections caused by Klebsiella pneumoniae carbapenemase (KPC) pose a significant clinical challenge due to increasing antibiotic resistance.
Patrycja Paschke, Igor Miczek, Maria Sambura, Sara Rosołowska-Żak, Julia Pałuchowska, Anna Szymkowicz   +5 more
doaj   +1 more source

Antimicrobial Resistance (AMR) and Multidrug Resistance (MDR): Overview of Current Approaches, Consortia and Intellectual Property Issues [PDF]

, 2017
The supply of new diagnostics and treatments is insufficient to keep up with the increase in antimicrobial resistance (AMR) and multidrug resistance (MDR) as older medicines are used more widely and microbes develop resistance to them.
Bhagwandin, Niresh, Jenner, Andrew, Kowalski, Stanley P.   +2 more
core   +1 more source

Risk factors for mortality in patients treated with ceftazidime-avibactam for ceftazidime-avibactam susceptible carbapenem-resistant Klebsiella pneumoniae bacteremia

Journal of Infection and Public Health
Background: Ceftazidime-avibactam (CZA) is the preferred treatment for infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP). This study aimed to investigate the prognostic factors of 28-day mortality and 14-day clinical failure in patients treated with CZA for CZA-susceptible CRKP bacteremia.
Yi-Tsung Lin, Shih-Neng Lin, Chien Chuang, Szu-Yu Liu, Yu-Chien Ho, Chih-Han Juan, Hsiang-Ling Ho, Sheng-Hua Chou   +7 more
openaire   +2 more sources

Role of Class I, II and III Integrons in Multidrug Resistance in Pseudomonas aeruginosa Isolated from Nosocomial Hospital [PDF]

, 2016
Aims: The increasing usage of antibiotics can cause resistance to the treatment of infections, which can caused by bacteria, e.g. Pseudomonas aeruginosa. The aim of this study was to trace the class I, II and III integrons in isolates of P. aeruginosa of
Momtaz, H., Nourbakhsh, F.
core   +1 more source

Rapid detection of extended-spectrum-β-lactamase-producing Enterobacteriaceae from urine samples by use of the ESBL NDP test [PDF]

, 2014
From June to September 2012, 500 urine samples were recovered from patients with urinary tract infections (UTI) due to Gram-negative bacilli (≥10⁴ leukocytes/ml and ≥10⁵ Gram-negative isolates/ml) who visited the University hospital Bicêtre (France ...
Dortet, Laurent, Nordmann, Patrice, Poirel, Laurent   +2 more
core   +1 more source

Clin Infect Dis [PDF]

The dramatic increase in the prevalence and clinical impact of infections caused by bacteria producing carbapenemases is a global health concern.

core  

Treatment Options for urinary tract infections caused by extended-spectrum B-lactamase-producing Escherichia coli and Klebsiella pneumoniae [PDF]

, 2015
Increased utilization of antibiotics has contributed to greater resistance among pathogenic bacteria. The prevalence of such organisms has created challenges for practitioners treating bacterial infections.
Resman-Targoff, Beth, Salvatore, Dominick   +1 more
core  

KPC variants conferring resistance to ceftazidime-avibactam in Pseudomonas aeruginosa strains

Microbiological Research
This study aimed to characterize three KPC variants (KPC-33, KPC-100, and KPC-201) obtained from a clinical isolate of Pseudomonas aeruginosa (#700), along with two induced strains C109 and C108.Genomic DNAs of #700 (ST235), C109 (ST463), and C108 (ST1076) were sequenced using Illumina and Oxford Nanopore technologies. The transferability and stability
Yanyan, Hu, Weiyi, Shen, Di, Lin, Yuchen, Wu, Yanyan, Zhang, Hongwei, Zhou, Rong, Zhang   +6 more
openaire   +2 more sources

Ceftazidime/Avibactam and Other Commonly Used Antibiotics Activity Against Enterobacterales and Pseudomonas aeruginosa Isolated in Poland in 2015–2019

Infection and Drug Resistance, 2022
Patrycja Zalas-Więcek,1 Małgorzata Prażyńska,1 Łukasz Pojnar,2 Anna Pałka,2 Dorota Żabicka,3 Monika Orczykowska-Kotyna,3 Aleksandra Polak,3 Barbara Możejko-Pastewka,4 Ewa Anna Głowacka,4 Izabela ...
Zalas-Więcek P, Prażyńska M, Pojnar Ł, Pałka A, Żabicka D, Orczykowska-Kotyna M, Polak A, Możejko-Pastewka B, Głowacka EA, Pieniążek I, Pawlik M, Grys M, Bogiel M   +12 more
doaj  

Antibiotic Susceptibility of Aerobic and Facultative Anaerobic Gram-Negative Rods in Hong Kong and Implications on Usefulness of Ceftazidime-Avibactam and Ceftolozane-Tazobactam

Antibiotics
Due to the increasing resistance of aerobic and facultative anaerobic Gram-negative rods, ceftazidime-avibactam and ceftolozane-tazobactam have been launched in the market in the last few years.
Jade L. L. Teng, Elaine Chan, Tsz Tuen Li, Tsz Ying Kwan, Ka Fai Chan, Wing Ho Li, Viki W. K. Tang, Man Lung Yeung, Susanna K. P. Lau, Patrick C. Y. Woo   +9 more
doaj   +1 more source